Certified by Founder Lodge
BOLD Capital Partners
United States - Santa Monica, California
INVESTOR
1 Disclosed Funding Rounds $43,200,000
14 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Early stage venture investing in life sciences, healthcare and frontier tech
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| December, 05 ,2022 | Series B | $43,200,000.00 |
| Company | Date | Round | Raised |
|---|---|---|---|
 Bionaut Labs |
December, 05 ,2022 | Series B | $43,200,000 |
 Dreamscape Immersive |
February, 02 ,2023 | Series A | $20,000,000 |
 Insilico Medicine |
June, 06 ,2022 | Series D | $60,000,000 |
 Crowdz |
May, 11 ,2022 | Unknown | $10,000,000 |
 Curebase |
May, 05 ,2022 | Series B | $40,000,000 |
 Rugged Robotics |
March, 23 ,2022 | Series A | $9,400,000 |
 Switch Therapeutics |
March, 15 ,2023 | Series A | $52,000,000 |
 Colossal Biosciences |
March, 09 ,2022 | Series A | $60,000,000 |
 Solarea Bio |
May, 09 ,2023 | Series B | $15,000,000 |
 Liquid AI |
December, 12 ,2023 | Seed | $37,600,000 |
 Gallant Therapeutics |
January, 09 ,2024 | Series A | $15,000,000 |
 Gameto |
May, 30 ,2024 | Series B | $33,000,000 |
 Feno |
September, 26 ,2024 | Seed | $6,000,000 |
 Esperto Medical |
February, 21 ,2025 | Series A |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
